MENLO PARK, Calif., July 20 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (Nasdaq: CONR - News) today announced that its second quarter 2006 financial results will be released Monday, July 24, 2006 after the market close and will be followed by a conference call at 4:30 PM Eastern time. Frank Litvack, M.D., Chairman and Chief Executive Officer, and Michael Boennighausen, Chief Financial Officer, will discuss the company’s operating and financial results and provide updates on the company’s commercialization efforts, clinical trials, product development activities, litigation and other business matters.
To access the live audio broadcast or the subsequent archived recording, visit the webcast section of the company’s website located at www.conormed.com. Please log on to Conor’s website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary. A replay of the web cast will remain at this location until such time as the company reports its financial results for the third quarter of 2006.
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com and institutional investors can access the call via www.streetevents.com. The dial-in number for the conference call is 866-362-4820 in the U.S., 617-597-5345 outside the U.S., and the participant passcode is 26610866.
About Conor Medsystems
Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug- eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit www.conormed.com.
Investor inquiries: Michael Boennighausen Chief Financial Officer 650-614-4100
Media inquiries: BCC Partners Karen L. Bergman 650-575-1509
Source: Conor Medsystems
